Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
51
¥ million (year-on-year improvement in profit before tax)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFirst quarter of the fiscal year ending December 20268 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥907 million-9.0%
Operating profit¥-118 million
Ordinary income¥-109 million profit before tax
Net income¥-79 million profit attributable to owners of the parent
Results for the three months of the current quarter
Revenue
¥907 million
Operating profit
¥-118 million
Income before taxes
¥-109 million
Profit for the period attributable to owners of the parent
¥-79 million
Full-year earnings forecast
Revenue
¥4,300 million
Operating profit
¥170 million
Income before taxes
¥173 million
Profit for the period attributable to owners of the parent
¥105 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Revenue21.1% (first-quarter progress against full-year forecast)
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing in line with the plan toward the full yearBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
RevenueDecrease in the number of part-time physician placements: -¥3 million; decrease in the number of full-time pharmacist placements: -¥3 million; decrease in income from contracted services for local governments: -¥83 million
Income before taxesRevenue: -¥89 million; decrease in advertising and promotional expenses: +¥85 million; decrease in personnel expenses: +¥51 million; decrease in fees paid and outsourcing costs: +¥12 million; decrease in product and merchandise costs: +¥8 million; allowance for doubtful accounts: +¥13 million; financial income and expenses: +¥10 million; other: +¥28 million
New initiatives
Continue investing in new services and overseas operationsKey KPIsA metric the company considers important as a management benchmark.
April monthly revenue from physician placements: ¥651 million, the highest ever on a year-on-year basis (excluding COVID-19-related business)Unit price and quantity metricsThese figures show sales broken down by price and volume.
Full-time placement revenue increased by ¥72 million and part-time placement revenue by ¥23 million, driven by an increase in the number of placementsSegment results
Healthcare Staffing ServicesRevenue down 1.0% year on year
Comedical ServicesDown 3.7% year on year
Other ServicesDown 23.8% year on year
Capital expenditures
¥26 million ¥13 million in tangible assets and ¥13 million in intangible assets
Acquisition of treasury shares
Expenditure on the acquisition of treasury shares: ¥27 million| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending December 2026 |
| Net Sales | ¥907 million (YoY -9.0%) |
| Operating profit | ¥-118 million |
| Ordinary income | ¥-109 million (profit before tax) |
| Net income | ¥-79 million (profit attributable to owners of the parent) |
| Results for the three months of the current quarter | Revenue ¥907 million / Operating profit ¥-118 million / Income before taxes ¥-109 million / Profit for the period attributable to owners of the parent ¥-79 million |
| Full-year earnings forecast | Revenue ¥4,300 million / Operating profit ¥170 million / Income before taxes ¥173 million / Profit for the period attributable to owners of the parent ¥105 million |
| Progress against full-year forecast | Revenue 21.1% (first-quarter progress against full-year forecast) |
| Self-assessment against the plan | Progressing in line with the plan toward the full year |
| Segment results | Healthcare Staffing Services Revenue down 1.0% year on year / Comedical Services Down 3.7% year on year / Other Services Down 23.8% year on year |
| Breakdown of Factors Affecting the Change | Revenue Decrease in the number of part-time physician placements: -¥3 million; decrease in the number of full-time pharmacist placements: -¥3 million; decrease in income from contracted services for local governments: -¥83 million / Income before taxes Revenue: -¥89 million; decrease in advertising and promotional expenses: +¥85 million; decrease in personnel expenses: +¥51 million; decrease in fees paid and outsourcing costs: +¥12 million; decrease in product and merchandise costs: +¥8 million; allowance for doubtful accounts: +¥13 million; financial income and expenses: +¥10 million; other: +¥28 million |
| Key KPIs | April monthly revenue from physician placements: ¥651 million, the highest ever on a year-on-year basis (excluding COVID-19-related business) |
| Unit price and quantity metrics | Full-time placement revenue increased by ¥72 million and part-time placement revenue by ¥23 million, driven by an increase in the number of placements |
| Acquisition of treasury shares | Expenditure on the acquisition of treasury shares: ¥27 million |
| Capital expenditures | ¥26 million (¥13 million in tangible assets and ¥13 million in intangible assets) |
| New initiatives | Continue investing in new services and overseas operations |
Items this document does not state (14)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue decreased mainly because of declines in the number of part-time physician placements, the number of full-time pharmacist placements, and income from contracted services for local governments. Operating profit improved mainly because of reductions in operating costs for BPO centers serving local governments, advertising and promotional expenses, personnel expenses, and fees paid and outsourcing costs.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.